alexa
Reach Us +1-217-403-9671
Adverse Drug Reaction-causality Assessment Scales | 7592
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Adverse drug reaction-causality assessment scales

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

N Chandra Sekhar

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Abstract
Adverse drug reaction according to WHO is defined as ?Any response to a drug which is noxious and unintended, and which occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function?. Adverse drug reaction (ADR) monitoring involves following steps 1. Identifying adverse drug reaction (ADR). 2. Assessing causality between drug and suspected reaction by using various algorithms. 3. Documentation of ADR in patient?s medical records. 4. Reporting serious ADRs to pharmacovigilance centers /ADR regulating authorities. For the assessment of causality between drug and suspected ADR, various causality assessment scales been used. Most commonly used causality assessment scales are Naranjo ADR probability scale and WHO?UMC causality categories. These causality assessment scales will be displayed and discussed during this poster presentation.
Biography
Top